New Zealand markets closed

ICON Public Limited Company (ICLR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
241.24-2.09 (-0.86%)
At close: 04:00PM EDT
241.24 0.00 (0.00%)
After hours: 04:00PM EDT

ICON Public Limited Company

South County Business Park
Leopardstown
Dublin 18
Ireland
353 1 291 2000
https://www.iconplc.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees40,500

Key executives

NameTitlePayExercisedYear born
Dr. Steven A. Cutler MBA, Ph.D.CEO & Director3.64MN/A1960
Mr. Brendan BrennanChief Financial Officer1.63MN/A1979
Jonathan CurtainSr. VP of Corp. & Commercial Fin.N/AN/AN/A
Mr. Thomas N. O'LearyChief Information OfficerN/AN/AN/A
Mr. Diarmaid CunninghamChief Admin. Officer, Gen. Counsel, Exec. VP & Company Sec.N/AN/A1975
Mr. Simon HolmesExec. VP of Investor Relations & Corp. Devel.N/AN/A1967
Ms. Niamh MurphyDirector of Corp. CommunicationsN/AN/AN/A
Mr. David GreenVP of MarketingN/AN/AN/A
Mr. Joe CroninChief HR OfficerN/AN/AN/A
Ms. Dana Lynn Poff Snr.Exec. VP of Program ManagementN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Corporate governance

ICON Public Limited Company’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.